The Discounted Cash Flow (DCF) valuation of Emergent BioSolutions Inc (EBS) is 10.37 USD. With the latest stock price at 11.41 USD, the upside of Emergent BioSolutions Inc based on DCF is -9.1%.
Based on the latest price of 11.41 USD and our DCF valuation, Emergent BioSolutions Inc (EBS) is a sell. selling EBS stocks now will result in a potential gain of 9.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.6% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 3.27 - 58.24 | 10.37 |
| Upside | -71.3% - 410.4% | -9.1% |